Sara Milchgrub
About
In The Last Decade
Sara Milchgrub
54 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 2.3k
- Oncology 1.2k
- Cancer Research 843
- Pulmonary and Respiratory Medicine 838
- Pathology and Forensic Medicine 579
Countries citing papers authored by Sara Milchgrub
This map shows the geographic impact of Sara Milchgrub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Milchgrub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Milchgrub more than expected).
Fields of papers citing papers by Sara Milchgrub
This network shows the impact of papers produced by Sara Milchgrub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Milchgrub. The network helps show where Sara Milchgrub may publish in the future.
Co-authorship network of co-authors of Sara Milchgrub
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Milchgrub. A scholar is included among the top collaborators of Sara Milchgrub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Milchgrub. Sara Milchgrub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 143 | |
| 3 | 32 | |
| 4 | 39 | |
| 5 | 123 | |
| 6 | 16 | |
| 7 | Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression breakdown → | 659 |
| 8 | 9 | |
| 9 | 9 | |
| 10 | 57 | |
| 11 | Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. | 76 |
| 12 | Comparison of features of human breast cancer cell lines and their corresponding tumors. | 124 |
| 13 | 166 | |
| 14 | Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. | 148 |
| 15 | 13 | |
| 16 | Intraductal papillary carcinoma of the main pancreatic duct | 7 |
| 17 | 17 | |
| 18 | 51 | |
| 19 | 28 | |
| 20 | 35 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.